miconazole has been researched along with Cancer of Head in 3 studies
Miconazole: An imidazole antifungal agent that is used topically and by intravenous infusion.
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group.
miconazole : A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two hundred eighty-two patients with head and neck cancer received a 14-day treatment of either single-dose MBT or MOG administered in 4 divided doses." | 2.73 | Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients ( Allavena, C; Attali, P; Bastit, L; Bensadoun, RJ; Calais, G; Céruse, P; Daoud, J; El Gueddari, B; Gourmet, R; Rosikon, A, 2008) |
| "Participants were patients with head and neck cancer receiving RT ≥ 60 Gy." | 1.72 | Effects of a miconazole oral patch on preventing development of oral candidiasis in patients with head and neck cancer undergoing radiotherapy: results of a preliminary study quantifying the prevalence of Candida albicans in saliva. ( Akashi, M; Funahara, M; Funahara, R; Hasegawa, T; Soutome, S; Tsuda, S; Umeda, M, 2022) |
| " The miconazole hydroxypropyl-beta-cyclodextrin product and genuine cyclodextrin inclusion complexes of miconazole, econazole and clotrimazole were toxic on a human TR146 buccal cell culture model." | 1.30 | Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity--drug supersaturation, toxicity on TR146 cells and release from a delivery system. ( Bjerregaard, S; Jacobsen, J; Pedersen, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Funahara, R | 1 |
| Soutome, S | 1 |
| Funahara, M | 1 |
| Tsuda, S | 1 |
| Hasegawa, T | 1 |
| Umeda, M | 1 |
| Akashi, M | 1 |
| Bensadoun, RJ | 1 |
| Daoud, J | 1 |
| El Gueddari, B | 1 |
| Bastit, L | 1 |
| Gourmet, R | 1 |
| Rosikon, A | 1 |
| Allavena, C | 1 |
| Céruse, P | 1 |
| Calais, G | 1 |
| Attali, P | 1 |
| Jacobsen, J | 1 |
| Bjerregaard, S | 1 |
| Pedersen, M | 1 |
1 trial available for miconazole and Cancer of Head
| Article | Year |
|---|---|
Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis, Oral; Female; Gels; Head | 2008 |
2 other studies available for miconazole and Cancer of Head
| Article | Year |
|---|---|
Effects of a miconazole oral patch on preventing development of oral candidiasis in patients with head and neck cancer undergoing radiotherapy: results of a preliminary study quantifying the prevalence of Candida albicans in saliva.
Topics: Candida albicans; Candidiasis, Oral; Head and Neck Neoplasms; Humans; Miconazole; Prevalence; Saliva | 2022 |
Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity--drug supersaturation, toxicity on TR146 cells and release from a delivery system.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antifungal Agents; beta-Cyclodextrins; Candida albicans; Carcinom | 1999 |